Ondansetron and Arrhythmia: An Adverse Effect, Medical Error, or Insufficient Guidelines

Authors

  • Majid Malaki

Abstract

Ondansetron is the most frequently administered antiemetic
in emergency medicine, but most adverse effects related
to ondansetron have been reported in operation rooms and
emergency wards by slowly infusion of single intravenous
dose of 4 mg that can be associated with different forms of
fatal arrhythmia such as bradycardia, ventricular tachycardia,
and atrial fibrillation that occurred during 2–15 min after
receiving drug.[1,2] Arrhythmia following ondansetron may
also be reported by intramuscular route, but it seems that such
catastrophic events may partly be related to a coincidence
underlying situations such as fatal infections due to an
intra-abdominal sepsis misleading us to ondansetron side
effect.[

Downloads

Published

2020-01-30

Issue

Section

Articles

How to Cite

Ondansetron and Arrhythmia: An Adverse Effect, Medical Error, or Insufficient Guidelines. (2020). Journal of Pharmaceutical Negative Results, 11(1), 75-76. https://pnrjournal.com/index.php/home/article/view/157